| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |